Vault-13

Bain Capital Investors LLC

Boston, MA · CIK 1040508 · 13F filing filed 2024-08-12

No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.

$4.7bn reported value +5.1% vs Q1 2024
5positions
100.0%in top 10
1 new 0 added 0 reduced 0 sold out vs Q1 2024

This report includes the holdings of 17 other managers that share the investment decisions:

9 more
  • BCPE Seminole GP LLC – no 13F of its own this quarter
  • BCPE Seminole Holdings II Intermediate LP – no 13F of its own this quarter
  • BCPE Seminole Holdings III, L.P. – no 13F of its own this quarter
  • BCPE Seminole Holdings IV, L.P. – no 13F of its own this quarter
  • BCPE Seminole Holdings LP – no 13F of its own this quarter
  • Bain Capital Fund XI, L.P. – no 13F of its own this quarter
  • Bain Capital Fund XII, L.P. – no 13F of its own this quarter
  • Bain Capital Partners XI, L.P. – no 13F of its own this quarter
  • Bain Capital Partners XII, LLC – no 13F of its own this quarter

Shares in two reports are counted once in each security's totals.

Holdings, Q2 2024

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 CEREVEL THERAPEUTICS HLDNG I COM CERE CERE 65,679,781 $2.7bn57.02% 57.02% UnchangedShares held: Q3 2023 60.2m, Q4 2023 65.7m, Q1 2024 65.7m, Q2 2024 65.7m
2 SURGERY PARTNERS INC COM SGRY SGRY 49,946,972 $1.2bn25.23% 25.23% UnchangedShares held: Q3 2023 58.2m, Q4 2023 49.9m, Q1 2024 49.9m, Q2 2024 49.9m
3 WAYSTAR HLDG CORP COM WAY WAY 27,980,417 $601.6m12.77% 12.77% NewShares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 28.0m
4 AVEANNA HEALTHCARE HLDGS INC COM AVAH AVAH 81,600,880 $225.2m4.78% 4.78% UnchangedShares held: Q3 2023 81.6m, Q4 2023 81.6m, Q1 2024 81.6m, Q2 2024 81.6m
5 ADVANTAGE SOLUTIONS INC COM CL A COM CL A 2,890,000 $9.3m0.20% 0.20% UnchangedShares held: Q3 2023 2.9m, Q4 2023 2.9m, Q1 2024 2.9m, Q2 2024 2.9m